167 related articles for article (PubMed ID: 11776308)
1. Localization of blood coagulation factors in situ in pancreatic carcinoma.
Wojtukiewicz MZ; Rucinska M; Zacharski LR; Kozlowski L; Zimnoch L; Piotrowski Z; Kudryk BJ; Kisiel W
Thromb Haemost; 2001 Dec; 86(6):1416-20. PubMed ID: 11776308
[TBL] [Abstract][Full Text] [Related]
2. Indirect activation of blood coagulation in colon cancer.
Wojtukiewicz MZ; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Rousseau SM; Stump DC
Thromb Haemost; 1989 Dec; 62(4):1062-6. PubMed ID: 2694422
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen-fibrin transformation in situ in renal cell carcinoma.
Wojtukiewicz MZ; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Rousseau SM; Stump DC
Anticancer Res; 1990; 10(3):579-82. PubMed ID: 2114816
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor-dependent coagulation activation and impaired fibrinolysis in situ in gastric cancer.
Wojtukiewicz MZ; Sierko E; Zacharski LR; Zimnoch L; Kudryk B; Kisiel W
Semin Thromb Hemost; 2003 Jun; 29(3):291-300. PubMed ID: 12888933
[TBL] [Abstract][Full Text] [Related]
5. Occurrence of components of fibrinolytic pathways in situ in laryngeal cancer.
Wojtukiewicz MZ; Sierko E; Zacharski LR; Rózanska-Kudelska M; Zimnoch L
Semin Thromb Hemost; 2003 Jun; 29(3):317-20. PubMed ID: 12888936
[TBL] [Abstract][Full Text] [Related]
6. [Expression evaluation of in loco coagulation system in colorectal cancer].
Sierko E; Tokajuk P; Butkiewicz A; Sulkowski S; Zimnoch L; Wojtukiewicz MZ
Pol Merkur Lekarski; 2005 Feb; 18(104):176-9. PubMed ID: 17877125
[TBL] [Abstract][Full Text] [Related]
7. Fibrin deposition in squamous cell carcinomas of the larynx and hypopharynx.
Bárdos H; Juhász A; Répássy G; Adány R
Thromb Haemost; 1998 Nov; 80(5):767-72. PubMed ID: 9843169
[TBL] [Abstract][Full Text] [Related]
8. Expression of tissue factor and tissue factor pathway inhibitor in situ in laryngeal carcinoma.
Wojtukiewicz MZ; Zacharski LR; Ruciñska M; Zimnoch L; Jaromin J; Rózañska-Kudelska M; Kisiel W; Kudryk BJ
Thromb Haemost; 1999 Dec; 82(6):1659-62. PubMed ID: 10613652
[TBL] [Abstract][Full Text] [Related]
9. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
[TBL] [Abstract][Full Text] [Related]
10. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
11. Cellular localization of enzymatically active thrombin in intact human tissues by hirudin binding.
Zacharski LR; Memoli VA; Morain WD; Schlaeppi JM; Rousseau SM
Thromb Haemost; 1995 May; 73(5):793-7. PubMed ID: 7482405
[TBL] [Abstract][Full Text] [Related]
12. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
13. Fibrin formation on vessel walls in hyperplastic and malignant prostate tissue.
Wojtukiewicz MZ; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Moritz TE; Rousseau SM; Stump DC
Cancer; 1991 Mar; 67(5):1377-83. PubMed ID: 1703919
[TBL] [Abstract][Full Text] [Related]
14. Cause of hematic cysts of the orbit: increased fibrinolysis and immunohistologic expression of tissue plasminogen activator.
Yoshikawa K; Fujisawa H; Kajiwara K; Fujii M; Kato S; Akimura T; Nomura S; Gondo T; Suzuki M
Ophthalmology; 2009 Jan; 116(1):130-4. PubMed ID: 19019445
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples.
Lewis MR; Callas PW; Jenny NS; Tracy RP
Thromb Haemost; 2001 Dec; 86(6):1495-500. PubMed ID: 11776319
[TBL] [Abstract][Full Text] [Related]
16. Fibrinogen deposition and macrophage-associated fibrin formation in malignant and nonmalignant lymphoid tissue.
Costantini V; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Rousseau SM; Stump DC
J Lab Clin Med; 1992 Feb; 119(2):124-31. PubMed ID: 1740624
[TBL] [Abstract][Full Text] [Related]
17. Abnormal regulation of coagulation/fibrinolysis in small cell carcinoma of the lung.
Wojtukiewicz MZ; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Rousseau SM; Stump DC
Cancer; 1990 Feb; 65(3):481-5. PubMed ID: 2153429
[TBL] [Abstract][Full Text] [Related]
18. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
[TBL] [Abstract][Full Text] [Related]
19. Hemostatic/fibrinolytic protein changes in C3H/HeN mice infected with Rickettsia conorii--a model for Rocky Mountain spotted fever.
Schmaier AH; Srikanth S; Elghetany MT; Normolle D; Gokhale S; Feng HM; Walker DH
Thromb Haemost; 2001 Sep; 86(3):871-9. PubMed ID: 11583321
[TBL] [Abstract][Full Text] [Related]
20. A characterization of the coagulant and fibrinolytic profile of human pancreatic carcinoma cells.
Kakkar AK; Chinswangwatanakul V; Tebbutt S; Lemoine NR; Williamson RC
Haemostasis; 1998; 28(1):1-6. PubMed ID: 9885363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
